Prysmian S.p.A. (PRYMY)

Verve Therapeutics Revenue

Prysmian had revenue of 4.94B EUR in the quarter ending June 30, 2025, with 19.15% growth. This brings the company's revenue in the last twelve months to 18.98B, up 24.78% year-over-year. In the year 2024, Prysmian had annual revenue of 17.10B with 10.98% growth.

• Revenue (ttm): 18.98B EUR
• Revenue Growth: +24.78%
• P/S Ratio: 1.02
• Revenue / Employee: 595.72K EUR
• Employees: 31,857
• Market Cap: 22.84B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	17.10B	1.69B	10.98%
Dec 31, 2023	15.40B	-709.00M	-4.40%
Dec 31, 2022	16.11B	3.27B	25.48%
Dec 31, 2021	12.84B	2.78B	27.61%
Dec 31, 2020	10.06B	-1.51B	-13.07%